164 related articles for article (PubMed ID: 28119029)
1. Analysis of expression of FLI1 and MMP1 in American cutaneous leishmaniasis caused by Leishmania braziliensis infection.
Almeida L; Silva JA; Andrade VM; Machado P; Jamieson SE; Carvalho EM; Blackwell JM; Castellucci LC
Infect Genet Evol; 2017 Apr; 49():212-220. PubMed ID: 28119029
[TBL] [Abstract][Full Text] [Related]
2. IL6 -174 G/C promoter polymorphism influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil.
Castellucci L; Menezes E; Oliveira J; Magalhaes A; Guimaraes LH; Lessa M; Ribeiro S; Reale J; Noronha EF; Wilson ME; Duggal P; Beaty TH; Jeronimo S; Jamieson SE; Bales A; Blackwell JM; de Jesus AR; Carvalho EM
J Infect Dis; 2006 Aug; 194(4):519-27. PubMed ID: 16845637
[TBL] [Abstract][Full Text] [Related]
3. Wound healing genes and susceptibility to cutaneous leishmaniasis in Brazil: role of COL1A1.
Almeida L; Oliveira J; Guimarães LH; Carvalho EM; Blackwell JM; Castellucci L
Infect Genet Evol; 2015 Mar; 30():225-229. PubMed ID: 25562121
[TBL] [Abstract][Full Text] [Related]
4. IL2RA genetic variants reduce IL-2-dependent responses and aggravate human cutaneous leishmaniasis.
Oliveira PR; Dessein H; Romano A; Cabantous S; de Brito ME; Santoro F; Pitta MG; Pereira V; Pontes-de-Carvalho LC; Rodrigues V; Rafati S; Argiro L; Dessein AJ
J Immunol; 2015 Mar; 194(6):2664-72. PubMed ID: 25672756
[TBL] [Abstract][Full Text] [Related]
5. Meta-transcriptome Profiling of the Human-Leishmania braziliensis Cutaneous Lesion.
Christensen SM; Dillon LA; Carvalho LP; Passos S; Novais FO; Hughitt VK; Beiting DP; Carvalho EM; Scott P; El-Sayed NM; Mosser DM
PLoS Negl Trop Dis; 2016 Sep; 10(9):e0004992. PubMed ID: 27631090
[TBL] [Abstract][Full Text] [Related]
6. IL-32γ promotes the healing of murine cutaneous lesions caused by Leishmania braziliensis infection in contrast to Leishmania amazonensis.
Gomes RS; Silva MVT; Dos Santos JC; de Lima Silva LL; Batista AC; Machado JR; Teixeira MM; Dorta ML; de Oliveira MAP; Dinarello CA; Joosten LAB; Ribeiro-Dias F
Parasit Vectors; 2017 Jul; 10(1):336. PubMed ID: 28709468
[TBL] [Abstract][Full Text] [Related]
7. Leishmania amazonensis downregulates macrophage iNOS expression via Histone Deacetylase 1 (HDAC1): a novel parasite evasion mechanism.
Calegari-Silva TC; Vivarini ÁC; Pereira RMS; Dias-Teixeira KL; Rath CT; Pacheco ASS; Silva GBL; Pinto CAS; Dos Santos JV; Saliba AM; Corbett CEP; de Castro Gomes CM; Fasel N; Lopes UG
Eur J Immunol; 2018 Jul; 48(7):1188-1198. PubMed ID: 29645094
[TBL] [Abstract][Full Text] [Related]
8. Molecular variants of Leishmania (Viannia) braziliensis trigger distinct patterns of cytokines and chemokines expression in golden hamster.
Rêgo FD; Fradico JRB; Teixeira-Carvalho A; Gontijo CMF
Mol Immunol; 2019 Feb; 106():36-45. PubMed ID: 30576950
[TBL] [Abstract][Full Text] [Related]
9. Homocysteine suppresses the expression of the collagen cross-linker lysyl oxidase involving IL-6, Fli1, and epigenetic DNA methylation.
Thaler R; Agsten M; Spitzer S; Paschalis EP; Karlic H; Klaushofer K; Varga F
J Biol Chem; 2011 Feb; 286(7):5578-88. PubMed ID: 21148317
[TBL] [Abstract][Full Text] [Related]
10. Study of association of the rs2275913 IL-17A single nucleotide polymorphism and susceptibility to cutaneous leishmaniasis caused by Leishmania braziliensis.
Gonçalves de Albuquerque SDC; da Costa Oliveira CN; Vaitkevicius-Antão V; Silva AC; Luna CF; de Lorena VMB; de Paiva-Cavalcanti M
Cytokine; 2019 Nov; 123():154784. PubMed ID: 31344596
[TBL] [Abstract][Full Text] [Related]
11. FLI1 polymorphism affects susceptibility to cutaneous leishmaniasis in Brazil.
Castellucci L; Jamieson SE; Miller EN; de Almeida LF; Oliveira J; Magalhães A; Guimarães LH; Lessa M; Lago E; de Jesus AR; Carvalho EM; Blackwell JM
Genes Immun; 2011 Oct; 12(7):589-94. PubMed ID: 21633373
[TBL] [Abstract][Full Text] [Related]
12. Changes in Macrophage Gene Expression Associated with Leishmania (Viannia) braziliensis Infection.
Ovalle-Bracho C; Franco-Muñoz C; Londoño-Barbosa D; Restrepo-Montoya D; Clavijo-Ramírez C
PLoS One; 2015; 10(6):e0128934. PubMed ID: 26052705
[TBL] [Abstract][Full Text] [Related]
13. The miRNA 361-3p, a Regulator of GZMB and TNF Is Associated With Therapeutic Failure and Longer Time Healing of Cutaneous Leishmaniasis Caused by
Lago TS; Silva JA; Lago EL; Carvalho EM; Zanette DL; Castellucci LC
Front Immunol; 2018; 9():2621. PubMed ID: 30487794
[No Abstract] [Full Text] [Related]
14. Development of real-time PCR assays for evaluation of immune response and parasite load in golden hamster (Mesocricetus auratus) infected by Leishmania (Viannia) braziliensis.
Ribeiro-Romão RP; Saavedra AF; Da-Cruz AM; Pinto EF; Moreira OC
Parasit Vectors; 2016 Jun; 9(1):361. PubMed ID: 27350537
[TBL] [Abstract][Full Text] [Related]
15. Immunological and genetic evidence for a crucial role of IL-10 in cutaneous lesions in humans infected with Leishmania braziliensis.
Salhi A; Rodrigues V; Santoro F; Dessein H; Romano A; Castellano LR; Sertorio M; Rafati S; Chevillard C; Prata A; Alcaïs A; Argiro L; Dessein A
J Immunol; 2008 May; 180(9):6139-48. PubMed ID: 18424735
[TBL] [Abstract][Full Text] [Related]
16. Gene Expression Profile of High IFN-γ Producers Stimulated with Leishmania braziliensis Identifies Genes Associated with Cutaneous Leishmaniasis.
Carneiro MW; Fukutani KF; Andrade BB; Curvelo RP; Cristal JR; Carvalho AM; Barral A; Van Weyenbergh J; Barral-Netto M; de Oliveira CI
PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005116. PubMed ID: 27870860
[TBL] [Abstract][Full Text] [Related]
17. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts.
Wang Y; Fan PS; Kahaleh B
Arthritis Rheum; 2006 Jul; 54(7):2271-9. PubMed ID: 16802366
[TBL] [Abstract][Full Text] [Related]
18. Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice.
Rocha FJ; Schleicher U; Mattner J; Alber G; Bogdan C
Infect Immun; 2007 Aug; 75(8):3823-32. PubMed ID: 17517868
[TBL] [Abstract][Full Text] [Related]
19. American cutaneous leishmaniasis: In situ immune response of patients with recent and late lesions.
Gomes AHS; Martines RB; Kanamura CT; Barbo MLP; Iglezias SD; Lauletta Lindoso JA; Pereira-Chioccola VL
Parasite Immunol; 2017 Apr; 39(4):. PubMed ID: 28239875
[TBL] [Abstract][Full Text] [Related]
20. Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis.
Silveira FT; Lainson R; De Castro Gomes CM; Laurenti MD; Corbett CE
Parasite Immunol; 2009 Aug; 31(8):423-31. PubMed ID: 19646206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
